Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

While interested in CAR-T therapies’ potential to achieve durable, drug-free remission in serious autoimmune conditions, the ...

UK scientists have explored the role of B cells and T cells in the development of uveitis among patients with juvenile ...

WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service agreement with ...

The Charles Street Jail, completed in 1851, housed some of Boston’s most notorious criminals for nearly 150 years. But in 1973, prisoners revolted over poor living conditions, and the jail was ...

The firm said it expects to advance development of cell therapies and radioconjugates for cancer, blood disorders, and autoimmune diseases in China.

AstraZeneca has risen as one of pharma’s most prolific investors in China, including a $630 million pledge last week for full rights to AbelZeta’s cell therapy for cancer.

Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this complete guide.

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...

Dr. Mobasher held several executive roles in industry, most recently CMO at BeiGeneIFLI contributed up to $9 million to Enterome’s private funding round in 2025Enterome has announced a series of ...

A bill to support public broadcasting stations in Washington through a 20-cent monthly surcharge on cell phone lines is set for a public hearing Friday.

This could add another piece of the puzzle for the discovery of drug targets and ultimately, the development of new drugs,’ ...